ME02846B - Phosphoramidates nucléosidiques - Google Patents

Phosphoramidates nucléosidiques

Info

Publication number
ME02846B
ME02846B MEP-2017-196A MEP19617A ME02846B ME 02846 B ME02846 B ME 02846B ME P19617 A MEP19617 A ME P19617A ME 02846 B ME02846 B ME 02846B
Authority
ME
Montenegro
Prior art keywords
perfluorophenoxy
propanoate
phosphoryl
phenoxy
pyridine
Prior art date
Application number
MEP-2017-196A
Other languages
German (de)
English (en)
Unknown language (me)
Inventor
Bruce S Ross
Michael Joseph Sofia
Ganapati Reddy Pamulapati
Suguna Rachakonda
Hai-Ren Zhang
Byoung-Kwon Chun
Peiyuan Wang
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/783,680 external-priority patent/US8642756B2/en
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Priority claimed from EP13159791.6A external-priority patent/EP2609923B1/fr
Publication of ME02846B publication Critical patent/ME02846B/fr

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MEP-2017-196A 2010-03-31 2011-03-31 Phosphoramidates nucléosidiques ME02846B (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31951310P 2010-03-31 2010-03-31
US31954810P 2010-03-31 2010-03-31
US12/783,680 US8642756B2 (en) 2009-05-20 2010-05-20 Nucleoside phosphoramidates
EP13159791.6A EP2609923B1 (fr) 2010-03-31 2011-03-31 Procede de crystallisation de (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate

Publications (1)

Publication Number Publication Date
ME02846B true ME02846B (fr) 2018-01-20

Family

ID=55359000

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2015-199A ME02294B (fr) 2010-03-31 2011-03-31 Phosphoramidates de nucléosides
MEP-2017-196A ME02846B (fr) 2010-03-31 2011-03-31 Phosphoramidates nucléosidiques

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-2015-199A ME02294B (fr) 2010-03-31 2011-03-31 Phosphoramidates de nucléosides

Country Status (4)

Country Link
BR (1) BR122013004621A2 (fr)
ME (2) ME02294B (fr)
RS (1) RS56229B1 (fr)
SI (1) SI2552930T1 (fr)

Also Published As

Publication number Publication date
SI2552930T1 (sl) 2016-02-29
ME02294B (fr) 2016-02-20
BR122013004621A2 (pt) 2016-11-22
RS56229B1 (sr) 2017-11-30

Similar Documents

Publication Publication Date Title
HRP20171267T1 (hr) Postupak za kristalizaciju (s)-izopropil 2-(((s)(perfluorofenoksi)(fenoksi)fosforil)amino)proanoata
WO2012170952A3 (fr) Composés pour l'administration de médicament ciblée et l'augmentation de l'activité arnsi
KR101720885B1 (ko) (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
WO2008142482A3 (fr) Composition
PH12013501197B1 (en) Indeno-fused ring compounds
IN2014MN01839A (fr)
MX2013002149A (es) Nuevo proceso para la preparacion de intermediarios utiles para la elaboracion de inhibidores de nep.
MX347429B (es) Cristales de múltiples componentes que comprenden dasatinib y formadores de cocristales seleccionados.
WO2008100921A3 (fr) Huile d'enrobage comprenant des sous-produits de la fabrication d'esters alkyliques d'acides gras et/ou de biodiesel
JP2016519165A5 (fr)
MX2013002150A (es) Proceso para la preparacion de intermediarios para la elaboracion de inhibidores de nep.
IN2014CN03482A (fr)
RU2013151867A (ru) Ингибиторы гидролазы амидов жирных кислот для лечения боли
AR071274A1 (es) Derivados de pregabalina , composiciones farmaceuticas que los contienen y proceso de preparacion de los mismos
PE20121743A1 (es) Derivados de piridina triciclicos, medicamentos que contienen tales compuestos, su uso y proceso para su preparacion
ME02846B (fr) Phosphoramidates nucléosidiques
IL220706A (en) Compounds whose molecule includes groups 2– (phenyl / troaryl) - [3,1] oxazolo [4,5– d] pyrimidine and carboxy, their hydrocarbyl esters, their preparation process and pharmaceutical preparations containing them
Fabris et al. The use of a lactonized statin side-chain precursor in a concise and efficient assembly of pitavastatin
WO2012112841A3 (fr) Préparation de sels d'acide [1,2,4]oxadiazol-3-yl]-ylique et formes cristallines et leur préparation
MY186194A (en) Pest control composition
IL220708A (en) Compounds whose molecule contains groups 2 - (phenyl / heteroaryl) - [3,1] oxazolo [4,5– d] pyrimidine and carboxy - (heterocyclic nitrogen) carbonyl, also a process for their preparation and pharmaceutical preparations containing them
PH12014502064A1 (en) Crystalline form of a succinate salt
EP2624693A4 (fr) Procédé de préparation d'intermédiaires de tolvaptan
IL278644B2 (en) A process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines and products obtainable therefrom
HRP20160407T1 (hr) Postupak za pripravu skopin estera di-(2-tienil) glikolne kiseline, međuprodukta u sintezi tiotropij bromida